Results 221 to 230 of about 93,749 (369)

Medical management pathways for Cushing's disease in pituitary tumors centers of excellence (PTCOEs). [PDF]

Pituitary
Giustina A, Uygur MM, Frara S, Barkan A, Biermasz NR, Chanson P, Freda P, Gadelha M, Haberbosch L, Kaiser UB, Lamberts S, Laws E, Nachtigall LB, Popovic V, Schilbach K, Lely AJV, Wass JAH, Melmed S, Casanueva FF.   +18 more
europepmc   +1 more source

Regulation of growth hormone mRNA synthesis by 3,5,3'-triiodo-L-thyronine in cultured growth hormone-producing rat pituitary tumor cells (GC cells). Dissociation between nuclear iodothyronine receptor concentration and growth hormone mRNA synthesis during the deoxyribonucleic acid synthesis phase of the cell cycle.

, 1985
M. H. KUMARA-SIRI, Martin I. Surks
openalex   +1 more source

Higher risk and earlier onset glaucoma in Cushing's syndrome

Acta Ophthalmologica, EarlyView.
Abstract Purpose Glaucoma incidence in patients with endogenous Cushing's syndrome (CS) has never been established. We aim to assess the risk for glaucoma among CS patients compared to controls and determine the age of disease onset. Methods A nationwide retrospective matched‐cohort study of patients with endogenous CS diagnosed between 2000 and 2023 ...
Yael Sharon, Tzipora Shochat, Yaron Rudman, Shiri Kushnir, Alon Zahavi, Ilan Shimon, Maria Fleseriu, Amit Akirov   +7 more
wiley   +1 more source

IL‐6 signaling in acute exercise and chronic training: Potential consequences for health and athletic performance

Scandinavian Journal of Medicine &Science in Sports, Volume 33, Issue 1, Page 4-19, January 2023., 2023
The cytokine interleukin‐6 (IL‐6) is involved in a diverse set of physiological processes. Traditionally, IL‐6 has been thought of in terms of its inflammatory actions during the acute phase response and in chronic conditions such as rheumatoid arthritis and obesity.
Dan Nash, Michael G. Hughes, Lee Butcher, Rebecca Aicheler, Paul Smith, Tom Cullen, Richard Webb   +6 more
wiley   +1 more source

The 5th Edition of the WHO Classification of Pituitary Tumors: Strengths and limitations. [PDF]

Brain Pathol
Lopes MB.
europepmc   +1 more source

Development of a bespoke phantom to optimize molecular PET imaging of pituitary tumors. [PDF]

EJNMMI Phys, 2023
Gillett D, Marsden D, Crawford R, Ballout S, MacFarlane J, van der Meulen M, Gillett B, Bird N, Heard S, Powlson AS, Santarius T, Mannion R, Kolias A, Harper I, Mendichovszky IA, Aloj L, Cheow H, Bashari W, Koulouri O, Gurnell M.   +19 more
europepmc   +1 more source

International Symposium on Pituitary Tumors [PDF]

, 1983

openalex   +1 more source

Establishment of a reference interval for urinary albumin‐to‐creatinine ratio in dogs

Veterinary Clinical Pathology, Volume 51, Issue 4, Page 585-590, December 2022., 2022
Abstract Background Albuminuria is an important marker of renal damage and can precede proteinuria; thus, it can be a useful analyte in the early diagnosis of kidney diseases. Albuminuria has also been found in dogs with hypertension, inflammatory, infectious, and neoplastic diseases.
Fruzsina Anna Falus, Zsuzsanna Vizi, Korinna Éva Szabó, Linda Müller, Jenő Reiczigel, Nándor Balogh, Ferenc Manczur   +6 more
wiley   +1 more source

Synchronous Posterior and Anterior Pituitary Tumors: A Case Report of a Hypothetic Paracrine Relationship. [PDF]

Asian J Neurosurg, 2023
Rubino F, Eichberg DG, Saad AG, Komotar RJ, Ivan ME.   +4 more
europepmc   +1 more source

Cumulative stressor exposure and cognitive functioning in late childhood: The role of inflammation

British Journal of Developmental Psychology, EarlyView.
Abstract This study examined whether the experience of stressors since infancy is related to executive function and social communication in late childhood via inflammation, using data from 4457 participants of the Avon Longitudinal Study of Parents and Children (ALSPAC).
Izabella Polgar‐Wiseman, Marta Francesconi, Eirini Flouri   +2 more
wiley   +1 more source